Endocrine therapy of breast cancer
Jonat, W.; Maass, H.
Zentralblatt für Gynakologie 109(10): 617-627
1987
ISSN/ISBN: 0044-4197 PMID: 2956805 Document Number: 302300
A survey is given about the value of endocrine especially adjuvant treatment of breast cancer, the necessary case selection procedure with aid of time- and therapy dependent hormonal receptor status using new introduced monoclonal antibodies and of the practical possibilities. Special attention was directed to the very potent substances with less side effects aminoglutethimide, tamoxifen and high dose medroxyprogesteronacetate.
Document emailed within 1 workday
Related Documents
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Yoshida, M.; Miura, S. 1984: Internal endocrine therapy of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 989-998
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Jakesz, R.; Hausmaninger, H. 1984: Adjuvant endocrine forms of therapy in breast cancer Wiener Klinische Wochenschrift 96(13): 492-499
Manikhas, A.G.; Skvortsov, V.A.; Manikhas, G.M.; Raskin, G.A.; Oganesian, A.S.; Shemerovskiĭ, A.K. 2011: Endocrine therapy for postmenopausal breast cancer (role of cycline D1) Voprosy Onkologii 57(5): 641-644
Cikes, M.; Pettavel, J. 1977: Selection of patients with breast cancer with regard to endocrine therapy Schweizerische Medizinische Wochenschrift 107(46): 1645-1655
De Luca, A.; Normanno, N. 2009: Endocrine therapy plus zoledronic acid in premenopausal breast cancer New England Journal of Medicine 360(22): 2368-2369; Author Reply 2369-2370
Kitamura, M.; Tominaga, T.; Hayashi, K.; Takahashi, I.; Kosaki, G. 1985: Preliminary report of adjuvant chemo-endocrine therapy for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 111-117
Ikeda, T. 1994: "State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 370-376
Nomura, Y. 1984: Present status of endocrine therapy of breast cancer: a surgeon's view Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 981-988
Chahine, G.; Howayek, M.; Atallah, D. 2009: Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse Le Journal Medical Libanais. Lebanese Medical Journal 57(2): 124-129
Tachibana, K.; Ohtake, T.; Saji, S. 2016: III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512
Manni, A.; Trujillo, J.E.; Pearson, O.H. 1980: Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival Cancer Treatment Reports 64(1): 111-116
Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Konishi, K.; Hasegawa, N.; Kaneko, H.; Iimura, Y.; Shoji, Y.; Kawabata, M. 2010: A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 111-113
Tominaga, T. 1983: Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 628-631
Nomura, Y.; Abe, Y.; Yamagata, J.; Takenaka, K. 1976: Possible retention of the estrogen-binding capacity after endocrine ablation therapy in the rat and human breast cancer Gan 67(1): 101-104
Iglódi, F. 1989: Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer Therapia Hungarica 37(4): 205-208
Gittens, P.; Mullen, G. 2019: The effects of fractional microablative CO 2 laser therapy on sexual function in postmenopausal women and women with a history of breast cancer treated with endocrine therapy Journal of Cosmetic and Laser Therapy 21(3): 127-131